An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

Clinical trial NCT00054912 · COMPLETED

Trial details

NCT number: NCT00054912
Sponsor: Epimmune
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colonic Neoplasms Colorectal Neoplasms

Start date: 2003-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.